Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma

IMP-3 Promotes Migration and Invasion of Melanoma Cells by Modulating the Expression of HMGA2 and Predicts Poor Prognosis in Melanoma

(2015) Yi-Shuan Sheen et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Prognostic factors for Taiwanese patients with cutaneous melanoma undergoing sentinel lymph node biopsy

(2015) Chiao-En Wu et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

BRAF V600 mutations and pathological features in Japanese melanoma patients

(2015) Naoya Yamazaki et al.   MELANOMA RESEARCH

The role of melanogenesis in regulation of melanoma behavior: Melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways

(2014) A. Slominski et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

IMP3 RNP Safe Houses Prevent miRNA-Directed HMGA2 mRNA Decay in Cancer and Development

(2014) Lars Jønson et al.   Cell Reports

Oncogene abnormalities in a series of primary melanomas of the sinonasal tract: NRAS mutations and cyclin D1 amplification are more frequent than KIT or BRAF mutations

(2013) Meriem Chraybi et al.   HUMAN PATHOLOGY

Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma

(2013) Anna A. Brożyna et al.   HUMAN PATHOLOGY

Melanoma Epidemic: An Analysis of Six Decades of Data From the Connecticut Tumor Registry

(2013) Alan C. Geller et al.   JOURNAL OF CLINICAL ONCOLOGY

Transcriptome Profiling Identifies HMGA2 as a Biomarker of Melanoma Progression and Prognosis

(2013) Leon Raskin et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Unique prognostic factors in acral lentiginous melanoma

(2012) Michael E. Egger et al.   AMERICAN JOURNAL OF SURGERY

Changes in the site distribution of common melanoma subtypes in Queensland, Australia over time: implications for public health campaigns

(2012) P.H. Youl et al.   BRITISH JOURNAL OF DERMATOLOGY

BRAF Mutations and KIT Aberrations and Their Clinicopathological Correlation in 202 Korean Melanomas

(2012) Sun A. Jin et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: A study of 522 consecutive cases

(2011) Zhihong Chi et al.   BMC CANCER

Diffuse Expression of RNA-Binding Protein IMP3 Predicts High-Stage Lymph Node Metastasis and Poor Prognosis in Colorectal Adenocarcinoma

(2009) Ray-Hwang Yuan et al.   ANNALS OF SURGICAL ONCOLOGY

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

IMP-3 expression in melanocytic lesions

(2009) Limin Yu et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Skin cancer trends among Asians living in Singapore from 1968 to 2006

(2009) Judy Sng et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Prognostic significance of insulin-like growth factor II mRNA-binding protein 3 expression in gastric adenocarcinoma

(2008) Y.-M. Jeng et al.   BRITISH JOURNAL OF SURGERY

RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma

(2008) Yung-Ming Jeng et al.   HEPATOLOGY

Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy

(2008) Anna A. Brożyna et al.   INTERNATIONAL JOURNAL OF CANCER

Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells

(2008) Andrzej Slominski et al.   INTERNATIONAL JOURNAL OF CANCER

IMP-3 is a novel progression marker in malignant melanoma

(2008) Jennifer G Pryor et al.   MODERN PATHOLOGY